Hikma products
Hikma develops, manufactures and markets pharmaceutical products in key therapeutic areas.
Our market share
Hikma is currently the leading regional pharmaceutical company in the MENA region. Through our well-established businesses across 17 MENA markets, we are helping to address the changing healthcare needs of the region and the growing demand for pharmaceuticals. The MENA pharmaceutical market, 2009
| Rank | Unit sales (million) | Value $ m | Avg Rx Value $ | Growth % | Market share % | |
| TOP 9 MENA MARKETS | 2,967 | 8,028.00 | 2.7 | 10 | 100 | |
| SANOFI-AVENTIS | 1 | 235 | 769 | 3.27 | -2.6 | 9.6 |
| GLAXOSMITHKLINE | 2 | 219 | 619 | 2.82 | 13 | 7.7 |
| PFIZER | 3 | 88 | 465 | 5.28 | 4.5 | 5.8 |
| NOVARTIS | 4 | 124 | 442 | 3.56 | 5.5 | 5.5 |
| HIKMA PHARMA | 5 | 88 | 294 | 3.33 | 12.4 | 3.7 |
| MERCK & CO | 6 | 33 | 231 | 7 | 3.1 | 2.9 |
| SPIMACO | 7 | 47 | 198 | 4.21 | 11.6 | 2.5 |
| ASTRAZENECA | 8 | 16 | 177 | 11.06 | 24 | 2.2 |
| BAYER | 9 | 45 | 167 | 3.71 | 3.7 | 2.1 |
| PHARCO | 10 | 176 | 138 | 0.78 | 14.1 | 1.7 |
Source: IMS Health, MAT December 2009. Private retail sales only. Hikma's performance in key MENA markets in 2009
Unit Growth % | Value Growth % | Rank | Market share % | |
| Jordan | 9.20% | 14.50% | ||
| HIKMA in Jordan | 0.20% | 12.90% | 1 | 12.90% |
| Algeria | 9.10% | -1.40% | ||
| HIKMA in Algeria | 9.20% | 3.30% | 2 | 6.90% |
| Saudi Arabia | 10.20% | 12.80% | ||
| HIKMA in Saudi Arabia | 14.90% | 18.50% | 4 | 5.40% |
| Egypt | 10.50% | 16.40% | ||
| HIKMA in Egypt | 14.30% | 17.00% | 19 | 1.40% |
Source: IMS Health, MAT December 2009. Private retail sales only.